Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “SANGAMO THERAPEUTICS FRANCE”

2 pharma patents match "SANGAMO THERAPEUTICS FRANCE" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 2 pharmaceutical patents matching "SANGAMO THERAPEUTICS FRANCE" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2 results for “SANGAMO THERAPEUTICS FRANCE” · 30,257 patents in full index Clear search

  1. US 11981739

    Chimeric antigen receptor specific for interleukin-23 receptor

    SANGAMO THERAPEUTICS FRANCE · Granted May 14, 2024 · Expires May 9, 2044

    granted
  2. US 11814432

    Anti-HLA-A2 antibodies, related chimeric antigen receptors, and uses thereof

    SANGAMO THERAPEUTICS FRANCE · Granted Nov 14, 2023 · Expires Nov 9, 2043

    granted